Jan Stampfuss

The effect of food on the absorption and pharmacokinetics of rivaroxaban

Jan Stampfuss, Dagmar Kubitza, Michael Becka et al. · International Journal of Clinical Pharmacology and Therapeutics · 2013 · 215 citations

Pharmacy, Pharmacokinetics, Pharmacology +15

Rivaroxaban and other novel oral anticoagulants: pharmacokinetics in healthy subjects, specific patient populations and relevance of coagulation monitoring

Wolfgang Mueck, Stephan Schwers, Jan Stampfuss · Thrombosis Journal · 2013 · 166 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacology +17

Pharmacological profile of asundexian, a novel, orally bioavailable inhibitor of factor XIa

Stefan Heitmeier, Mayken Visser, Adrian Tersteegen et al. · Journal of Thrombosis and Haemostasis · 2022 · 88 citations · Full text

Medicine, Hematology, Pharmacology +17

Pharmacokinetics of rivaroxaban in children using physiologically based and population pharmacokinetic modelling: an EINSTEIN-Jr phase I study

Stefan Willmann, Kirstin Thelen, Dagmar Kubitza et al. · Thrombosis Journal · 2018 · 55 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacology +17

Nitric Oxide–Independent Soluble Guanylate Cyclase Activation Improves Vascular Function and Cardiac Remodeling in Sickle Cell Disease

Karin P. Potoka, Katherine C. Wood, Jeffrey Baust et al. · American Journal of Respiratory Cell and Molecular Biology · 2017 · 33 citations · Full text

Medicine, Cardiology, Pharmacology +15